PSTX
Poseida Therapeutics, Inc.
Price:  
9.51 
USD
Volume:  
743,463.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PSTX WACC - Weighted Average Cost of Capital

The WACC of Poseida Therapeutics, Inc. (PSTX) is 8.2%.

The Cost of Equity of Poseida Therapeutics, Inc. (PSTX) is 8.25%.
The Cost of Debt of Poseida Therapeutics, Inc. (PSTX) is 9.85%.

Range Selected
Cost of equity 6.90% - 9.60% 8.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 12.70% 9.85%
WACC 6.8% - 9.6% 8.2%
WACC

PSTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.06 0.06
Cost of debt 7.00% 12.70%
After-tax WACC 6.8% 9.6%
Selected WACC 8.2%